November 6, 2018Press ReleaseCalidi Biotherapeutics Announces Two Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual MeetingSAN DIEGO, Nov. 6, 2018 — Calidi Biotherapeutics, Inc., a clinical‐stage biotherapeutics company at the…
